Sermorelin is a synthetic copy of the first 29 amino acids of GHRH, the signal your body uses to trigger growth hormone release. It has a short half-life of around 10 to 20 minutes [verify: source] and was FDA-approved for growth hormone deficiency in children [verify: source]. It is widely used off-label in adults.

Tesamorelin is a modified GHRH analog with a longer active window than sermorelin [verify: source]. It is FDA-approved for HIV-associated belly fat buildup (lipodystrophy) [verify: source]. Research doses range from 1 mg to 2 mg per day [verify: source].

How do sermorelin and tesamorelin compare on potency?

Tesamorelin is more potent and has a longer active window than sermorelin [verify: source]. It also has stronger clinical evidence for visceral fat reduction in its studied population [verify: source]. Sermorelin is milder and used more broadly off-label for general GH support.

Which GHRH peptide do people choose for anti-aging or GH support?

Sermorelin is more commonly chosen for general off-label GH support because it is gentler and more broadly prescribed by anti-aging clinics [verify: source]. Tesamorelin is chosen when visceral belly fat is a specific target, especially in the population it was studied in. This is general guidance, not personalized medical advice.

Sermorelin vs Tesamorelin: Which Boosts GH Better?

Built by medical professionals, gym rats, and experienced biohackers

Tesamorelin is more potent with stronger clinical evidence for belly fat; sermorelin is milder and used more broadly off-label for general growth hormone support.

Quick Answer
Sermorelin is for people who want a gentle, off-label GHRH peptide for general GH support and anti-aging purposes. Tesamorelin is for people who want a more potent GHRH analog with FDA-backed evidence for visceral belly fat reduction in a specific patient population. The verdict: tesamorelin is stronger, but sermorelin is more broadly used because it fits a wider range of off-label goals.

Both sermorelin and tesamorelin are GHRH analogs. GHRH stands for growth hormone releasing hormone. It is your body's natural signal for telling the pituitary gland to release growth hormone (GH).

Both peptides copy this signal. They do it in slightly different ways and stay active for different lengths of time.

What Is Sermorelin?

Sermorelin is a synthetic copy of the first 29 amino acids of natural GHRH. Natural GHRH has 44 amino acids total, so sermorelin is a shorter fragment that still activates the same GHRH receptor .

It has a short half-life of roughly 10 to 20 minutes after injection , which means it triggers a brief GH pulse before it breaks down. Typical research doses range from 200 mcg to 500 mcg per injection .

Sermorelin was FDA-approved for growth hormone deficiency in children . Anti-aging clinics now commonly prescribe it off-label for adults who want GH support without using synthetic growth hormone directly. It is considered one of the gentler, more physiological ways to raise GH output.

What Is Tesamorelin?

Tesamorelin is a modified version of full-length GHRH. A chemical stabilizer was added to help it last longer in the body . This gives it a longer active window than sermorelin.

This gives tesamorelin a longer working window than sermorelin. The result is a stronger, more sustained GH signal per injection . Research doses range from 1 mg to 2 mg per day .

Tesamorelin is FDA-approved for a specific condition . It targets the buildup of belly fat around the organs in people with HIV on antiretroviral therapy. This buildup is called visceral fat, or lipodystrophy.

In that 26-week clinical trial population, tesamorelin produced meaningful reductions in visceral fat . This is its approved indication and where its strongest evidence lives.

How Do Sermorelin and Tesamorelin Compare?

Both peptides hit the GHRH receptor, but tesamorelin's modified structure gives it a longer, stronger effect.

Mechanism: Sermorelin copies the first 29 amino acids of GHRH. Tesamorelin copies the full 44-amino-acid GHRH structure with a stabilizing modification . Both trigger pituitary GH release through the same receptor.

Primary use: Sermorelin is used off-label for general GH support and anti-aging in adults. Tesamorelin is FDA-approved for HIV-associated visceral belly fat in its specific approved population .

Typical research dose:
- Sermorelin: 200 mcg to 500 mcg per injection
- Tesamorelin: 1 mg to 2 mg per day

Onset: Both start raising GH within the first weeks of use. Tesamorelin's belly fat effects were measured over a 26-week trial period . Sermorelin's off-label adult effects typically become noticeable over similar timeframes, though formal data is limited .

Evidence level: Tesamorelin has completed Phase 3 trials for its approved indication with strong results . Sermorelin's evidence for adult off-label use is much thinner . Honest flag: sermorelin is widely used in anti-aging clinics. Its adult data is not as strong as tesamorelin's approved-use trial data.

Keeping a log of your injection schedule and lab results makes it much easier to evaluate progress. DoseVault is built for exactly this kind of GHRH protocol tracking.

How Do Sermorelin and Tesamorelin Compare Side by Side?

Feature	Sermorelin	Tesamorelin
Receptor targeted	GHRH receptor	GHRH receptor
Structure	First 29 amino acids of GHRH	Full GHRH with stabilizing modification
Half-life after injection	Roughly 10 to 20 minutes	Longer due to modification
Typical research dose	200 to 500 mcg per injection	1 to 2 mg per day
FDA approval	Children with GH deficiency	HIV-associated visceral fat
Belly fat evidence	Limited for off-label use	Strong for approved population
Common off-label use	Adult anti-aging and GH support	Off-label body composition

Which One Do People Pick, and When?

Most anti-aging clinics prescribe sermorelin for off-label GH support in adults. It is the gentler option with a longer off-label track record, even if the clinical data behind adult use is limited .

People targeting visceral belly fat who have access to tesamorelin often find the clinical evidence more compelling. The evidence for tesamorelin reducing belly fat is real and well-documented for its studied population .

Neither peptide is typically stacked with the other because they act on the same receptor. However, either one can be paired with a GHRP such as ipamorelin or GHRP-2. GHRPs act on the ghrelin receptor, a completely separate system, and the combination produces an additive GH effect . This GHRH plus GHRP combination is common in the research and clinic setting.

This is general guidance, not personalized medical advice.

Disclaimer

This page is for educational purposes only. It is not medical advice. Nothing here should be used to diagnose, treat, cure, or prevent any condition. Sermorelin and tesamorelin are prescription compounds; tesamorelin is approved only for a specific indication. Consult a qualified healthcare provider before using either compound.

Built by medical professionals, gym rats, and experienced biohackers

Track your sermorelin or tesamorelin protocol, lab results, and weekly progress with DoseVault, a tool built for people who want clear records of their peptide or hormone support plan.